Fig. 2From: Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activitySerum IL-36γ levels among the 30 HC, 28 AQP4-IgG (+) and 22 AQP4-IgG (−) in NMOSD patients. AQP4-IgG (+) = AQP4-IgG-positive; AQP4-IgG (−) = AQP4-IgG-negative. *P < 0.05, **P < 0.01, ***P < 0.001Back to article page